2024澳科资料1688-资料免费精选
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2022.01.29
PROFIT WARNING ANNOUNCEMENT ON THE ESTIMATED DECREASE IN PROFIT FOR THE ANNUAL ...
2022.01.27
VOLUNTARY ANNOUNCEMENT LAUNCH OF HEPARIN SODIUM INJECTION IN THE USA
2022.01.04
Overseas Regulatory Announcement
2022.01.04
POLL RESULTS OF THE 2022 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 4 JANUARY 2...
2021.12.13
Notification Letter and Request Form to Non-Registered Shareholders
2021.12.13
NOTICE OF THE 2022 FIRST EXTRAORDINARY GENERAL MEETING
2021.12.13
PROXY FORM FOR THE 2022 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESDA...
2021.12.13
(1) PROPOSED ISSUANCE OF CORPORATE BONDS AND (2) NOTICE OF THE 2022 FIRST EXTRAO...
2021.12.10
Overseas Regulatory Announcement
2021.12.10
Overseas Regulatory Announcement
第一页
上一页
7
8
9
10
11
下一页
最后一页
